Analyst Price Targets — ACOG
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| July 10, 2026 10:12 am | Ryan Deschner | Raymond James | $20.00 | $8.52 | TheFly | Alpha Cognition initiated with an Outperform at Raymond James |
| May 29, 2026 11:46 am | — | Maxim Group | $12.00 | $5.85 | TheFly | Alpha Cognition initiated with a Buy at Maxim |
| April 17, 2026 11:31 am | — | Craig-Hallum | $14.00 | $6.65 | TheFly | Alpha Cognition initiated with a Buy at Craig-Hallum |
| October 20, 2025 12:20 pm | — | H.C. Wainwright | $18.00 | $6.80 | TheFly | Alpha Cognition price target lowered to $18 from $20 at H.C. Wainwright |
Latest News for ACOG
VANCOUVER, British Columbia & DALLAS--(BUSINESS WIRE)--Alpha Cognition Inc. (Nasdaq: ACOG) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company focused on developing novel therapies for debilitating neurodegenerative disorders, today announced Michael McFadden, Chief Executive Officer, will participate in the Late-Stage & Commercial CNS Small Cap panel discussion during the upcoming B. Riley Securities…
Alpha Cognition Inc. (Nasdaq: ACOG) (âAlpha Cognitionâ, or the âCompanyâ), a biopharmaceutical company focused on developing novel therapies for debili
VANCOUVER, British Columbia & DALLAS--(BUSINESS WIRE)--Alpha Cognition Inc. (Nasdaq: ACOG) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company focused on developing novel therapies for debilitating neurodegenerative disorders, today announced changes to its Board of Directors. Robert Wills has been elected Chairman of the Board, succeeding Len Mertz, who has retired from the Board after years of…
VANCOUVER, British Columbia & GRAPEVINE, Texas--(BUSINESS WIRE)--Alpha Cognition, Inc. (ACOG: NASDAQ) (“Alpha Cognition” or the “Company”), a biopharmaceutical company dedicated to developing innovative therapies for neurodegenerative diseases, today announced the enrollment of the first patient in RESOLVE, a Phase 4 post-marketing clinical study designed to further evaluate the tolerability profile and treatment…
Alpha Cognition Inc. (NASDAQ: ACOG) (âAlpha Cognitionâ, âACIâ, or the âCompanyâ), a biopharmaceutical company developing novel therapeutics for deb
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for ACOG.
U.S. House Trading
No House trades found for ACOG.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.